Inactive Instrument
Lotus Pharmaceuticals, Inc. Stock Other OTC
Stocks
LTUS
US5457152032
Pharmaceuticals
OTC Markets Traded
| Market Cap | 9.74M 8.46M 7.79M 7.32M 13.72M 920M 13.88M 92.45M 35.9M 452M 36.54M 35.76M 1.56B | P/E 2009 |
3.88x | P/E 2010 | 4.84x |
|---|---|---|---|---|---|
| Enterprise Value | 14.38M 12.5M 11.5M 10.82M 20.27M 1.36B 20.51M 137M 53.03M 668M 53.98M 52.82M 2.31B | EV / Sales 2009 |
1.02x | EV / Sales 2010 | 0.95x |
| Free-Float |
99% | Yield 2009 * |
-
| Yield 2010 | - |
| 1 day | +41.51% |
| Manager | Title | Age | Since |
|---|---|---|---|
Georgene Rivers
CEO | Chief Executive Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Georgene Rivers
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +41.51% | -18.92% | - | - | 9.12M | |
| +1.09% | +2.33% | +8.02% | +83.51% | 45.7B | |
| +2.03% | +2.87% | +46.54% | +90.11% | 34B | |
| -1.63% | -1.87% | -11.54% | +34.27% | 11.73B | |
| -1.60% | -4.00% | +8.93% | +92.61% | 11.48B | |
| +1.54% | +3.12% | +39.68% | +130.57% | 9.28B | |
| -0.92% | -0.34% | +17.53% | +40.48% | 7.21B | |
| -0.42% | +1.63% | +44.06% | -18.50% | 6.62B | |
| -0.93% | -3.30% | +26.92% | +232.57% | 6.44B | |
| -0.63% | -4.16% | -44.00% | -7.82% | 5.01B | |
| Average | +4.00% | -0.04% | +15.13% | +75.31% | 15.27B | |
| Weighted average by Cap. | +0.56% | +0.50% | +19.31% | +81.36% |
| 2009 | 2010 | |
|---|---|---|
| Net sales | 57.82M 50.26M 46.24M 43.49M 81.51M 5.47B 82.44M 549M 213M 2.68B 217M 212M 9.29B | 72.7M 63.19M 58.14M 54.68M 102M 6.87B 104M 690M 268M 3.38B 273M 267M 11.68B |
| Net income | 16.43M 14.28M 13.14M 12.36M 23.16M 1.55B 23.43M 156M 60.59M 763M 61.67M 60.35M 2.64B | 14.42M 12.54M 11.54M 10.85M 20.33M 1.36B 20.57M 137M 53.19M 670M 54.14M 52.98M 2.32B |
| Net Debt | 5.29 4.6 4.23 3.98 7.46 500.35 7.55 50.27 19.52 245.78 19.87 19.44 850.19 | 4.65 4.04 3.72 3.49 6.55 439.19 6.62 44.13 17.13 215.73 17.44 17.07 746.27 |
Employees
-
Sector
Pharmaceuticals
